Akari Therapeutics, PH1, PCT Patent, ADC, Antibody Drug Conjugate, RNA Splicing, Alternative Splicing, Thailanstatin, Spliceosome Modulator, AKTX-101, AKTX-102, Trop2, CEACAM5

TAMPA, Fla. and LONDON — October 1, 2026 Akari Therapeutics, Plc announced the filing of PCT/US2026/45955, expanding its intellectual...